NILK-2301
N/A
Report date: 2026/03/19 17:03:29
Base Information
Drug NameNILK-2301
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovimmune Sa
China Registration ClassN/A
Develop Information
Active CompaniesLamKap Bio Alpha AGLight Chain Bioscience Ltd
Inactive CompaniesNovimmune Sa
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A